Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
671,281
-
Share change
-
-121,417
-
Total reported value
-
$10,201,395
-
Price per share
-
$15.20
-
Number of holders
-
19
-
Value change
-
-$1,651,873
-
Number of buys
-
8
-
Number of sells
-
10
Institutional Holders of Greenwich LifeSciences, Inc. - COM (GLSI) as of Q4 2022
As of 31 Dec 2022 Greenwich LifeSciences, Inc. - COM (GLSI) had 19 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 671,281 shares of stock of the company.
Largest 10 holders included VANGUARD GROUP INC, AMERIPRISE FINANCIAL INC, BlackRock Inc., MARSHALL WACE, LLP, GEODE CAPITAL MANAGEMENT, LLC, MILLENNIUM MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, GSA CAPITAL PARTNERS LLP, and 683 Capital Management, LLC.
This table shows 19 institutional shareholders of the security as of 31 Dec 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.